Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments

Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
Drug Metabolism and Disposition April 2000, 28 (4) 475-481;
Kanji Komatsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyomi Ito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yukiko Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shin-ichi Kanamitsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susumu Imaoka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiko Funae
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol E. Green
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles A. Tyson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriaki Shimada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichi Sugiyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 28 no. 4 475-481
PubMed 
10725317

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 26, 1999
  • Accepted January 10, 2000
  • Published online April 1, 2000.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kanji Komatsu1,
  2. Kiyomi Ito2,
  3. Yukiko Nakajima1,
  4. Shin-ichi Kanamitsu1,
  5. Susumu Imaoka3,
  6. Yoshihiko Funae3,
  7. Carol E. Green4,
  8. Charles A. Tyson4,
  9. Noriaki Shimada5 and
  10. Yuichi Sugiyama1
  1. 1Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan (K.K., Y.N., S.K., Y.S.); 2School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan (K.I.); 3Laboratory of Chemistry, Osaka City University Medical School, Osaka, Japan (S.I., Y.F.); 4Toxicology Laboratory, SRI International, Menlo Park, California (C.E.G., C.A.T.); 5Research and Development Division, Daiichi Pure Chemicals Co., Ltd., Osaka, Japan (N.S.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to March 2023

    AbstractFullPdf
    Aug 20172298
    Sep 20174327
    Oct 20172328
    Nov 20174258
    Dec 201771714
    Jan 201833112
    Feb 20185219
    Mar 20182196
    Apr 20181196
    May 20182126
    Jun 20182218
    Jul 201882727
    Aug 20187137
    Sep 20180158
    Oct 201812510
    Nov 2018185
    Dec 20181325
    Jan 20191943
    Feb 20191340
    Mar 2019810
    Apr 20191018
    May 20191133
    Jun 20191402
    Jul 20192212
    Aug 20191400
    Oct 20191110
    Nov 20193523
    Dec 20192494
    Jan 20201221
    Feb 20201041
    Mar 20201332
    May 20204123
    Jun 20202301
    Jul 2020511
    Aug 20201012
    Sep 20201443
    Oct 20203310
    Nov 20203947
    Dec 20202144
    Jan 202116132
    Feb 202115143
    Mar 20213446
    Apr 20211473
    May 20212853
    Jun 202124124
    Jul 20211830
    Aug 2021994
    Sep 20211040
    Oct 20211241
    Nov 20212312
    Dec 20211730
    Jan 20222362
    Feb 20221210
    Mar 20223043
    Apr 20221533
    May 20221721
    Jun 20221201
    Jul 20222551
    Aug 20221131
    Sep 20223572
    Oct 202216111
    Nov 20222310
    Dec 20221110
    Jan 20232150
    Feb 20231653
    Mar 20231110

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition: 28 (4)
    Drug Metabolism and Disposition
    Vol. 28, Issue 4
    1 Apr 2000
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments

    Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
    Drug Metabolism and Disposition April 1, 2000, 28 (4) 475-481;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments

    Kanji Komatsu, Kiyomi Ito, Yukiko Nakajima, Shin-ichi Kanamitsu, Susumu Imaoka, Yoshihiko Funae, Carol E. Green, Charles A. Tyson, Noriaki Shimada and Yuichi Sugiyama
    Drug Metabolism and Disposition April 1, 2000, 28 (4) 475-481;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Metabolic enzymes in nintedanib metabolism
    • Mechanism of AO Inactivation by Hydralazine
    • Warfarin PBPK modeling with target binding
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics